Rep. Earl L. “Buddy” Carter (R-GA) leads a bipartisan group of House members who want to bring drug production onshore.
Warren piles on — attacking MA plans. Private insurers have a “long history of exploiting the government out of billions of dollars,” she says.
Yglesias: The problem with the media is the audience.
2 thoughts on “Thursday Links”
Is it Medicaid expansion itself reducing employment (i.e. reducing the need to seek employer-sponsored insurance), or is it the associated tax/benefit cliffs and tax bubbles? We see the same with Obamacare, Medicare (IRMAA), the Social Security tax torpedo, and surely other programs as well. It’s hard to believe anything so irrational could be deliberate, but they shouldn’t have been difficult to mitigate had there been the desire to do so.
Drugs made domestically: On the one hand the FDA can inspect more often and more easily if drugs are made in the U.S. On the other hand, drugs made abroad can be stopped from entering the drug supply chain more easily with import detention. The problem is the FDA does not inspect foreign firms often enough and the FDA investigators do not have the power to crack down on violators. The latter is because Congress comes to the rescue when drug companies complain about the FDA shutting down their production lines.